SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Genzyme Tissue Repair (GZTR)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Skeeter Bug who wrote (2371)12/17/1998 2:41:00 PM
From: BWAC  Read Replies (2) of 2553
 
Anybody ever thought of selling short GENZ say 1000 shares at 42 or $42,000. And buying $42,000 worth of GENZL and GZMO which would be about 20,000 shares worth as a hedge against the short? Theory being that if GENZ and GZMO do good then GENZ will but not on as much of a percentage. And same if GENZ does bad it falls, and how much further could the tracking stocks fall below 2?

So one could be short 1000 GENZ at 42. And long 10,000 GENZL and long 10,000 GZMO. If GENZL or GZMO sneeze right they could double to $5 and return about $40,000 profit. And GENZ might only move to $50 producing a $8,000 loss for example.

Think this is a workable strategy?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News